Explore
Trendline
Servier Invests $2.65 Billion in Edgewise's Muscular Dystrophy Drug Development
Servier Invests $2.65 Billion in Edgewise's Muscular Dystrophy Drug Development
Read More
Trendline
USA Rare Earth Expands Investment in France with $200 Million Commitment
USA Rare Earth Expands Investment in France with $200 Million Commitment
Read More
Trendline
Hanmi and Lilly Enter Licensing Agreement for Sonefpeglutide Development
Hanmi and Lilly Enter Licensing Agreement for Sonefpeglutide Development
Read More
Trendline
SoftBank Announces $87.5 Billion Investment in AI Infrastructure in France
SoftBank Announces $87.5 Billion Investment in AI Infrastructure in France
Read More
Trendline
Biohaven Targets Obesity Market to Recover from Clinical Setbacks
Biohaven Targets Obesity Market to Recover from Clinical Setbacks
Read More
Trendpost
The Basketball Fan’s Second-Level Guide to the FIFA World Cup
Understand the World Cup like a pro. This guide translates key soccer tactics and player roles into concepts every basketball fan will recognize.
Read More
Trendpost
10 Days, 10 Number 10s: The Best Players Ever to Wear It at the FIFA World Cup, Ranked
From Pelé to Messi, we rank the ten greatest players to ever wear the iconic number 10 jersey on the FIFA World Cup stage.
Read More
Trendpost
The Dark Horse Nations Casual Fans Should Never Ignore
Beyond the usual powerhouses, these dark horse nations consistently deliver drama, upsets, and excitement in major international tournaments.
Read More
Trendpost
Myth vs Fact: Is the Group of Death Always Obvious?
The 'Group of Death' is a beloved soccer tournament trope, but are the most hyped groups actually the most difficult? We explore the myth vs. the reality.
Read More
Trendline
Pfizer and Innovent Biologics Forge $10.5 Billion Oncology Partnership, Boosting Innovent Shares
Pfizer and Innovent Biologics Forge $10.5 Billion Oncology Partnership, Boosting Innovent Shares
Read More
Trendline
Innovent Biologics Shares Surge After $10.5 Billion Deal with Pfizer
Innovent Biologics Shares Surge After $10.5 Billion Deal with Pfizer
Read More
Trendline
Innovent Biologics and Pfizer Sign $10.5 Billion Oncology Deal Impacting Global Markets
Innovent Biologics and Pfizer Sign $10.5 Billion Oncology Deal Impacting Global Markets
Read More